Home > Boards > Free Zone > Health and Sciences > Biotech Values

More on the FDA’s 23andMe ruling:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 754
Posts 116,326
Boards Moderated 10
Alias Born 09/05/02
160x600 placeholder
Top Stories of the Day
TOP STORIES Restaurant Brands More Than Doubles 2Q Profit, Increases Buyback Authorization
Walt Disney to Require U.S. Employees to be Vaccinated
Top Company News of the Day
J&J Won't Be Held Liable For Illinois Woman's Death in Talc Case -- Reuters
Norfolk Southern Raises Quarterly Dividend by 10 Cents to $1.09/Share
Front Month Nymex RBOB Gasoline Rose 5.41% This Month to Settle at $2.3659 -- Data Talk
Front Month Nymex Natural Gas Rose 7.23% This Month to Settle at $3.9140 -- Data Talk
Soybeans Slide as Traders Liquidate -- Daily Grain Highlights
Regeneron Gets Expanded EUA for Covid-19 Antibody Cocktail -- Update
Regeneron Gets Expanded EUA for Covid-19 Antibody Cocktail
Unemployment Rate Seen Ticking Down to 5.7% -- Data Week Ahead
Gopuff Reaches $15 Billion Valuation With $1 Billion From Blackstone, SoftBank and Others
EURO STOXX 50 Index Ends the Month 0.62% Higher at 4089.30 -- Data Talk
FTSE 100 Index Ends the Month 0.07% Lower at 7032.30 -- Data Talk
STOXX Europe 600 Index Ends the Month 1.97% Higher at 461.74 -- Data Talk
DAX Ends the Month 0.09% Higher at 15544.39 -- Data Talk
STOXX Europe 50 Index Ends the Month 1.23% Higher at 3555.81 -- Data Talk
London Shares End Month With Mixed Results
Colgate-Palmolive On Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Caterpillar Worst Performer in the DJIA So Far Today -- Data Talk
Amazon.com Down Over 7%, on Pace for Largest Percent Decrease Since May 2020 -- Data Talk
ArcelorMittal, Canada Government to Invest $1.42 Billion in Carbon-Cutting Technology
Caterpillar Reports Favorable Currency Impact on 2Q Sales -- Currency Comment
Daimler Management, Board Approve Truck Spinoff
Chicago Business Barometer Rises in July
U.S. Personal Spending +1.0% in June -- Update
U.S. Personal Spending +1.0% in June
DewDiligence Member Level  Friday, 02/20/15 08:39:27 PM
Re: DewDiligence post# 187694
Post # of 238980 
More on the FDA’s 23andMe ruling:

http://www.wsj.com/articles/fda-signals-easier-rule-on-genetic-tests-1424468927
Quote:
Alberto Gutierrez, director of the FDA’s office of in vitro diagnostics and radiological health, said the dividing line between light and stringent FDA regulation “is risk-based; it’s what people can do with the results.”

With these tests, they are unlikely, for example, to get radical surgery, as is the case with some genetic breast-cancer tests. They won’t take, or forgo taking, a certain critical medicine. They will instead likely get their spouses tested and get counseling about having children.

With a Bloom syndrome test, “the risk that people planning to have children will both get false results is very small,” said Dr. Gutierrez.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences